927
Views
1
CrossRef citations to date
0
Altmetric
Original Research

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

ORCID Icon ORCID Icon, , , ORCID Icon, , ORCID Icon, , , ORCID Icon & show all
Article: e1465164 | Received 05 Feb 2018, Accepted 09 Apr 2018, Published online: 11 Jun 2018